All files are PDFs (26–885 KB).
The Translational Genomics Research Institute (TGen) North has a unique partnership with Northern Arizona University (NAU), joining the ranks of facilities across the country whose research centers on the detection and prevention of biological threats. TGen’s initial research activities focus on common infectious diseases like influenza and valley fever, hospital infections like drug resistant staphylococcus, and a number of bioterrorism agents, including tularemia and plague.
TGen North is led by Dr. Paul Keim, one of the world’s foremost experts in anthrax and other dangerous infectious diseases. Dr. Keim is a professor of biology and the Cowden Endowed Chair in Microbiology at NAU.
The company’s strategic plan focuses on diagnostic, analytic, forensic, and epidemiologic research. These activities are linked across four research centers: